MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Clinical profile of early-onset Parkinson’s disease

    S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)

    Objective: Describe motor and non-motor symptoms, complications and treatment in patients with early-onset Parkinson's disease (EOPD) Background: PD usually affecting people over age 60, clinically…
  • 2024 International Congress

    Enhancing Real-Life Gait Performance in Persons with Parkinson Disease through the Music-Based BeatWalk Application

    A. Bourdon, V. Cochen, B. Bardy, L. Damm (France, France)

    Objective: The goal of this study was to explore real life data collected during a gait rehabilitation program with music on Persons with Parkinson Disease.…
  • 2024 International Congress

    The Prospect of Exoskeletons for Individuals with Parkinson’s Disease: A Comprehensive Review

    MYA. Amine, G. Bekheet, M. Sadek, S. Kastantin (Giza, Egypt)

    Objective: This comprehensive review provides a thorough analysis of the effects of robotic-assisted gait training on Parkinson's disease patients' gait parameters and makes recommendations for…
  • 2024 International Congress

    The role of cognitive functions on the outcomes of an intensive multidisciplinary rehabilitation program for people with Parkinson’s disease

    L. Ricciardi, P. Ortelli, MC. Campo, D. Ferrazzoli, F. Morgante, J. Goldman, D. Volpe (London, United Kingdom)

    Objective: This study examined relationships among cognitive functions and rehabilitation outcomes in patients with Parkinson's disease (PD) during a 4-week intensive, multidisciplinary rehabilitation program (Vicenza,…
  • 2024 International Congress

    State of happiness as outcome measure in sleep disorders in Parkinson’s disease

    I. Murasan, S. Diaconu, L. Ungureanu, R. Filip, L. Irincu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: The objective of this study was to evaluate state of hapiness as outcome measure in sleep disorders in PD. Background: Outcome measures are very…
  • 2024 International Congress

    Combining MDS-UPDRS Parts 1 and 2: using the patient’s voice

    C. Goetz, H. Zou, G. Stebbins, A. Schrag, T. Mestre, S. Luo (Chicago, USA)

    Objective: To test whether the patient-derived MDS-UPDRS Parts assessing non-motor (Part 1) and motor (Part 2) functional impact of PD can be summed to render…
  • 2024 International Congress

    Cervical percutaneous interferential current stimulation improves cough reflex and oral residue in patients with Parkinson’s disease

    M. Nakamori, M. Toko, H. Yamada, Y. Hayashi, K. Yoshikawa, A. Hiraoka, M. Yoshikawa, T. Nagasaki, Y. Mikami, H. Maruyama (Hiroshima, Japan)

    Objective: Patients with Parkinson's disease (PD) encounter various swallowing disorders. This study aimed to assess the effects of cervical percutaneous interferential current stimulation on pharyngeal…
  • 2024 International Congress

    Opicapone as First-Line Strategy for the Treatment of Wearing-off in Korean Patients with Parkinson’s Disease

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aimed to explore the efficacy of opicapone (OPC) 50 mg versus an extra 100 mg levodopa (L-dopa) dose to treat early wearing-off…
  • 2024 International Congress

    Long-Term Safety and Efficacy of Foscarbidopa/Foslevodopa in Patients with Advanced Parkinson’s Disease: Results From an Ongoing Phase 3 Open-Label Extension with Up to 1 Year Follow-Up

    R. Hauser, V. Fung, T. Kimber, K. Klos, M. Facheris, A. Jeong, J. Jia, A. Spiegel, M. Soileau (Tampa, USA)

    Objective: Evaluate long-term safety and efficacy of foslevodopa/foscarbidopa (LDp/CDp) among people with advanced Parkinson’s disease (aPD). Background: As aPD progresses, erratic gastric emptying and pulsatile…
  • 2024 International Congress

    Effects of Mental Practice on FOG in People with Parkinson’s Disease: a Randomized Clinical Trial

    P. Silva, K. Honda, I. Nascimento, K. Nobrega, N. Pereira, T. Barolli (Sao Paulo, Brazil)

    Objective: To compare the effects of an experimental intervention (EI) based on NCI with a control intervention (CI) of equal volume and intensity, differing only…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley